Esaote will showcase Prevention Suite, a unique package of ultrasound imaging modalities for both cardiac and vascular investigations at the EuroEcho-Imaging 2013 conference Dec. 11-14 in Istanbul, Turkey.


The use of renal stenting in combination with medication-based therapy to treat hypertension showed no improvement in patient outcomes over the use of medications alone in treating hypertension. The results from the highly-anticipated CORAL trial were presented at the American Heart Assn. (AHA) 2013 Scientific Sessions in Dallas.



AtriCure Inc., a developer of solutions to treat atrial fibrillation, announced the U.S. Food and Drug Administration’s (FDA’s) approval to begin enrollment in a clinical study of AtriCure’s AtriClip Left Atrial Appendage Exclusion System.


Five global MRI manufacturers—in the United States, Europe and Asia—have selected ContextVision’s GOPView MRI2Plus to upgrade their MRI equipment. Today’s healthcare industry requires improved efficiencies without sacrificing patient safety. As radiologists around the world review an increasing number of MRI images every day, image quality is key. 


Fractional flow reserve (FFR) is considered the gold standard in determining the hemodynamic significance of coronary lesions, but its use remains low. Two new technologies may help increase its use. 



A German court ordered Nov. 14 the discontinuation of a prior court ruling that prohibited Medtronic from commercially marketing or selling the CoreValve transcatheter aortic valve replacement (TAVR) system in Germany since Aug. 26, 2013.


GE Healthcare will introduce new software to help humanize magnetic resonance imaging (MRI) with the DV24.0 Continuum Pak Silent Scan noiseless MRI at the Radiological Society of North America 2013 Annual Meeting (RSNA 2013) in Chicago.

Subscribe Now